Entering China in 1916, Air Liquide operates nearly 90 plants in over 40 cities with approximately 3,700 employees nationwide today. Its main business includes industrial and medical gas operations, Engineering & Construction via its dedicated division, as well as innovation activities by advanced Business & Technologies and Shanghai Research & Technology Center. With a strong presence in the key coastal industrial areas, Air Liquide is further expanding into the center, south and west of China.
Air Liquide pursues profitable and sustainable growth over the long term through delivering excellent performance and acting responsibly, while maintaining a leading position in China. It relies on operational excellence, selective investments, open innovation and a network organization to meet today's challenges and to create new markets and opportunities with a focus on the energy, environment, high technology, and healthcare sectors. With dedicated support from its professional teams, Air Liquide China is committed to providing reliable services and value-added solutions to its customers while fulfilling its role as a responsible corporate citizen.
A world leader in gases, technologies and services for Industry and Health, Air Liquide is present in 80 countries with approximately 65,000 employees and serves more than 3,5 million customers and patients.
2017 Group revenue
customers and patients
Oxygen, nitrogen and hydrogen are essential small molecules for life, matter and energy. They embody Air Liquide’s scientific territory and have been at the core of the company’s activities since its creation in 1902.
Air Liquide’s ambition is to lead its industry, deliver long term performance and contribute to sustainability. The company’s customer-centric transformation strategy aims at profitable growth over the long term. It relies on operational excellence, selective investments, open innovation and a network organization implemented by the Group worldwide. Through the commitment and inventiveness of its people, Air Liquide leverages energy and environment transition, changes in healthcare and digitization, and delivers greater value to all its stakeholders.
Air Liquide’s revenue amounted to € 20.3 billion in 2017 and its solutions that protect life and the environment represented more than 40% of sales. Air Liquide is listed on the Euronext Paris stock exchange (compartment A) and belongs to the CAC 40, Euro STOXX 50 and FTSE4Good indexes.
Creative Oxygen is the signature we use in every country in which we are present. The word creative conveys the permanent capacity for invention on the part of Air Liquide’s employees, while the word oxygen is a reminder of Air Liquide’s history. Oxygen is the source of the Group’s development and is a vital resource for industry and health. More than just a molecule, oxygen is a source of inspiration for our employees, who are working to create new applications, for existing markets and those of tomorrow.
Innovation is part of Air Liquide's open ecosystem. Its Innovation and Development teams combine scientific and technological expertise with an entrepreneurial spirit. With a portfolio of more than 11,000 patents, Air Liquide files more than 300 new inventions each year and develops. In partnership with external ecosystems, the teams design and deploy new offerings to improve the customer and patient experience.
The Shanghai Innovation Campus (SIC) launched in 2016 is with experienced researchers and experts as well as advanced equipment. SIC enables Air Liquide to enhance innovative R&D work in China and foster its collaborations with local renowned universities and public institutes in China. It helps Chinese customers and consumers benefit from Air Liquide's innovative solutions and global innovation network to tackle environmental and societal challenges.
Follow our social media accounts to learn the latest news and events of Air Liquide China: